How to evaluate a GLP-1 telehealth program: a due diligence guide

The GLP-1 telehealth market has exploded. Dozens of providers now offer online access to semaglutide, tirzepatide, and compounded alternatives. Some run responsible clinical programs; others prioritize volume over patient safety. This guide gives you a framework for evaluating any GLP-1 telehealth program before you subscribe — covering clinical oversight, medication sourcing, cost transparency, support quality, and the specific red flags that should make you walk away.

Clinical oversight: the most important dimension

The quality of clinical oversight determines whether you are receiving medical care or participating in a medication dispensing operation. Evaluate:

• Who reviews your intake? Look for licensed physicians, nurse practitioners, or physician assistants. Verify that the prescriber is licensed in your state — telehealth prescribing is state-regulated.

• How thorough is the intake? A responsible program asks about thyroid cancer history, MEN 2, pregnancy status, pancreatitis history, current medications, mental health, and kidney function. If the intake fits on a single screen with 5 dropdown questions, the clinical review is inadequate.

• Is the clinician review synchronous or asynchronous? Synchronous (video or phone) reviews allow the clinician to ask follow-up questions. Asynchronous (chart-only) reviews are faster but rely entirely on what the patient self-reports.

• Can the program say no? A responsible program should turn away patients who have contraindications or who would be better served by in-person care. If the approval rate is advertised as 95%+, question whether the screening is meaningful.

• What happens between visits? Ongoing monitoring should include scheduled check-ins during dose escalation, a way to reach a clinician for urgent side effects, and periodic lab review if indicated.

Medication sourcing: branded vs compounded

This is the second most important evaluation dimension and the one most likely to affect your safety:

• Does the program clearly disclose whether the medication is branded (FDA-approved) or compounded (not FDA-approved)?

• If compounded: which pharmacy compounds it? Is the pharmacy 503A (patient-specific) or 503B (outsourcing facility)? Does the pharmacy publish third-party potency and sterility testing results?

• If compounded semaglutide: does the provider acknowledge that FDA enforcement against compounded semaglutide has increased since the drug was removed from the shortage list in February 2025?

• What salt form is used? Compounded semaglutide sodium is a different chemical entity from the semaglutide base used in Wegovy. The FDA does not consider them interchangeable.

• If a provider sells both branded and compounded options, do they clearly separate the two on their website, in their intake, and in their pricing?

Cost transparency: what the real price is

Apply these tests to any GLP-1 program pricing:

• Is the advertised price for the starting dose or the maintenance dose? The maintenance dose is what you will pay for the majority of your treatment.

• What is included in the monthly price? Separate out: medication, clinician access, shipping, lab work, coaching, and any platform or membership fee.

• Is the pricing month-to-month, or does it require a multi-month commitment? What is the cancellation and refund policy?

• Does the price change when the dose increases? For dose-dependent pricing, request a full schedule for all dose levels.

• Are there any mandatory upfront fees (intake, enrollment, initial labs) that are separate from the monthly price?

Support quality: what you get between prescriptions

The medication is only one part of GLP-1 treatment. Evaluate the support infrastructure:

• Clinician messaging: can you reach a prescriber between scheduled visits? What is the typical response time?

• Side effect management: does the program have a protocol for common GI issues during dose escalation? Can they adjust your schedule without a full new consultation?

• Nutrition and lifestyle support: does the program include dietitian access, meal planning, or structured coaching? Or is it medication-only?

• Lab coordination: if labs are needed, does the program order them, accept outside results, or leave it entirely to the patient?

• Transition support: if you need to switch medications, change providers, or transition to in-person care, does the program facilitate that — or does your clinical record disappear?

Red flags: when to walk away

The evaluation checklist

How to use GLP-1 Scout to compare programs

GLP-1 Scout reviews each provider against these dimensions. Use the compare page to filter by medication type and price, then read the full review for each shortlisted provider. Our reviews cover clinical structure, medication sourcing, pricing transparency, and support quality — the same framework in this guide.